USPTO serial 79372972
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Handelsman
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.1950 Roland Clarke PlaceReston, VA 20191-1411United States| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Educational services in the nature of providing instruction in the field of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms and information services relating thereto; arranging, conducting and organization of seminars in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms and information services relating thereto, namely, providing information about seminars in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms; development of educational curricula in the field of science, medicine, health, biomedicine, pharmacology, biology and physics and information services relating thereto, namely, providing information about development of educational curricula in the field of science, medicine, health, biomedicine, pharmacology, biology and physics; providing information in the field of education; research in the field of education; publishing of journals, books and handbooks in the field of medicine; publication of books, periodical publications, magazines, newspapers and newsletters; educational services relating to anti-aging, namely, providing instruction in the field of anti-aging; provision of educational courses in the field of diet and health care; higher education, academic, linguistic and vocational education and training services, namely, providing courses of instruction in the academic field of science for the purpose of academic study; training for handling scientific instruments and apparatus for research in laboratories; educational examination services; arranging and conducting of symposiums in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms; arranging and conducting of workshops in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms; planning, arranging, organization and conducting of seminars, symposiums, conferences, lectures, workshops and research meetings in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms; organization of exhibitions for cultural or educational purposes; research library services; dubbing; providing on-line magazines in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms, not downloadable; providing on-line newsletters in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms, not downloadable; providing online non-downloadable electronic publications in the nature of books and brochures in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms; providing online non-downloadable videos in the fields of life science, manufacturing processes of pharmaceuticals and analysis of microorganisms; providing television programmes, not downloadable, via video-on-demand services; production of videotape film in the field of education, culture, entertainment or sports, not for movies or television programs and not for advertising or publicity; rental of sound recordings; rental of videotapes; photography; interpretation and translation services | ACTIVE | — |
| 042 | Research and development in the field of microorganisms and cells and information services relating thereto; research services in the field of proteins, antibodies, microorganisms and cells and information services relating thereto, namely, providing information about research services in the field of proteins, antibodies, microorganisms and cells; chemical, biochemical, biological and bacteriological research and analysis and information services relating thereto, namely, providing information about chemical, biochemical, biological and bacteriological research and analysis; biological research; biological research laboratory services; biomedical research services; biotechnological research; biology consultancy; research in the fields of chemistry, biology and physics; chemistry services, namely, chemistry consultation, research in the field of chemistry and research laboratory analysis services in the field of chemistry; providing information in the nature of scientific research in the fields of biochemistry and biotechnology; research in the field of nanobiotechnology; biotechnology research; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; medical research; bacteriological research; stem cell research services; pharmaceutical research; providing information about medical and scientific research in the field of pharmaceuticals; provision of information in the field of technological research; research in the field of human reproductive science; scientific services in the field of the isolation and cultivation of human tissues and cells; structural and functional analysis of genomes; research and development services in the field of immunology; research and development services in the field of antibodies; cell culture services for scientific and research purposes, for others; conducting clinical trials for others, namely, scientific research; design and development of endoprostheses; research and development of new products for others; providing information in the field of product development; research and development services relating to medicines; preparation of biological samples for research purposes; quantum computing, namely, consultancy in the field of quantum computing and research in the field of quantum computing; scientific research in the field of quantum computing; research in the field of artificial intelligence technology; computer programming; software engineering services for data processing; development of computer platforms; rental of laboratory apparatus and instruments | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 28, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 28, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 15, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 15, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 15, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 25, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 25, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 19, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 30, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 14, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 27, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 28, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 24, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 28, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 28, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 28, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 9, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 25, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 10, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 30, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 30, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 30, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 30, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 30, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 26, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 4, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 4, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 10, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 9, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |